Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05487196 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia

A Phase 2 study, sponsored by Grace Lim, MD, MS.

Completed
Registry status
Phase 2
Development phase
88
Enrollment target

NCT05487196 is a Phase 2 study that has completed, run by Grace Lim, MD, MS. The registered enrollment target is 88 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05487196, a Phase 2 study, has completed, sponsored by Grace Lim, MD, MS.

COMPLETED
Registry status
Phase 2
Development phase
88 participants
Enrollment target

Study Summary

The purpose of this randomized controlled trial is to compare the effectiveness of epidural clonidine, dexmedetomidine, or fentanyl adjuncts for labor analgesia.

Interventions

  • DRUG Dexmedetomidine
  • DRUG Ropivacaine
  • DRUG Fentanyl
  • DRUG Clonidine

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2022-09-28
Est. Completion 2023-07-31
Phase Phase 2

Sponsor

Grace Lim, MD, MS

10 total trials

What the Registry Record Tells You About NCT05487196

The ClinicalTrials.gov registry entry for NCT05487196 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Grace Lim, MD, MS, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Dexmedetomidine is the first listed.

NCT05487196 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05487196 about?

NCT05487196 is a clinical study titled "Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia". The purpose of this randomized controlled trial is to compare the effectiveness of epidural clonidine, dexmedetomidine, or fentanyl adjuncts for labor analgesia.

What is the current status of trial NCT05487196?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2022-09-28. Estimated completion is 2023-07-31.

What interventions are being tested in trial NCT05487196?

The interventions under investigation include: Dexmedetomidine (DRUG), Ropivacaine (DRUG), Fentanyl (DRUG), Clonidine (DRUG).

Who is sponsoring clinical trial NCT05487196?

This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.